So I'm thinking the upsid from this result is big.
The PFS has come in better than pluvicto and as we are an antibody not a small molecule, we will hang around and fight off the cancer for longer again therefore showing increased Overall survival.
Plus our dosing regime is only 2 doses, compared to 6 for pluvicto.
There may be a number of reasons why one would want to take 591 over pluvicto
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS, page-17
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.77 |
Change
-0.550(2.85%) |
Mkt cap ! $6.187B | |||
| Open | High | Low | Value | Volume |
| $18.82 | $18.87 | $17.60 | $32.37M | 1.756M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 296 | $18.77 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.78 | 142 | 4 |
View Market Depth
| Last trade - 13.43pm 31/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |